Krilogy Financial’s Zomedica Corp. ZOM Stock Holding History

Krilogy Financial’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-10,000	Closed	-$2K	–	244
2020 Q2	$2K	Buy	+10,000	New	+$1.91K	﹤0.01%	217

Other funds holding ZOM

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Krilogy Financial's ZOM Position: Q3 2020 in Review

Krilogy Financial sold out of Zomedica Corp. (ZOM) in Q3 2020, closing a stake of 10,000 shares — an estimated $2K sold.

Krilogy Financial first reported a position in ZOM in Q2 2020 and held it in 1 quarter. The position peaked at $2K in Q2 2020. 32 funds tracked by Wall St. Rank hold ZOM as of Q3 2020.

Krilogy Financial reported no remaining Zomedica Corp. position as of Q3 2020 after selling out during the quarter.
Krilogy Financial sold 10,000 Zomedica Corp. shares in Q3 2020, an estimated $2K.
Krilogy Financial first reported a position in Zomedica Corp. in Q2 2020 and held it in 1 quarter.
Krilogy Financial's Zomedica Corp. position peaked at $2K in Q2 2020.
32 funds tracked by Wall St. Rank held Zomedica Corp. as of Q3 2020.

Based on Krilogy Financial's 13F filing for Q3 2020, filed 13 Nov 2020.